Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma

NCT00744640 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Pancreatic Cancer
Metastatic Pancreatic Cancer

Interventions

DRUG: gemcitabine, oxaliplatin, capecitabine

Sponsor

University Hospital, Basel, Switzerland

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]